Respiratory panic attacks and COVID-19 Contact details: Kotova O.V. — PhD (medicine), Associate Professor of the Department of Psychiatry, Psychotherapy and Psychosomatic Pathology Address: 45 Dubninskaya St., building 1, apt. 1, Moscow, Russian Federation, 127174, tel.: +7-903-117-99-83, e-mail: [email protected] The unpredictability of the COVID-19 spread and the pandemic has led to a loss of self-control in many people, to anxiety and panic. Social restrictions due to the new coronavirus infection also negatively affected the mental and social well-being of the population. Under these conditions, the mental disorders incidence, including panic disorders, has increased significantly and has attracted attention to this problem as one of the current pandemic consequences. Panic attacks can have a significant respiratory component. In such cases, panic attacks are called respiratory attacks, and their clinical manifestations may be similar to some of the COVID-19 symptoms. For example, coughing and breathlessness are common in coronavirus infection and are potentially considered by patients as а high risk symptoms of an adverse outcome, and cause fear of developing acute respiratory distress syndrome. Due to the possibility of the increase of the respiratory panic attacks prevalence after the COVID-19 pandemic has regressed, the relevance of timely detection and adequate treatment of panic disorder is increasing. Key words: panic attacks, hyperventilation syndrome, respiratory panic attacks, panic disorder, COVID-19

2021 ◽  
Vol 19 (1) ◽  
pp. 29-33
Author(s):  
O. V. Kotova ◽  
◽  
A. R. Artemenko ◽  
A. A. Belyaev ◽  
E. S. Akarachkova ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Distress Syndrome ◽  
Clinical Manifestations ◽  
Well Being ◽  
Self Control ◽  
Panic Attacks ◽  
Adequate Treatment ◽  
Panic Disorders ◽  
Loss Of Self ◽  
Coronavirus Infection

The unpredictability of the COVID-19 spread and the pandemic has led to a loss of self-control in many people, to anxiety and panic. Social restrictions due to the new coronavirus infection also negatively affected the mental and social well-being of the population. Under these conditions, the mental disorders incidence, including panic disorders, has increased significantly and has attracted attention to this problem as one of the current pandemic consequences. Panic attacks can have a significant respiratory component. In such cases, panic attacks are called respiratory attacks, and their clinical manifestations may be similar to some of the COVID-19 symptoms. For example, coughing and breathlessness are common in coronavirus infection and are potentially considered by patients as а high risk symptoms of an adverse outcome, and cause fear of developing acute respiratory distress syndrome. Due to the possibility of the increase of the respiratory panic attacks prevalence after the COVID-19 pandemic has regressed, the relevance of timely detection and adequate treatment of panic disorder is increasing.

scholarly journals Panic Disorder with Choking Phobia : a Case Report

2020 ◽  
Vol 1 (2) ◽  
pp. 25-30
Author(s):  
Patricia Wulandari
Keyword(s):  
Case Report ◽  
Panic Disorder ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Panic Attack ◽  
The Body ◽  
Self Control ◽  
Panic Attacks ◽  
Cognitive Behavior ◽  
Loss Of Self

Abstract   Panic disorder is a form of anxiety disorder characterized by repeated panic attacks and preoccupied with worrying that a panic attack will occur. Panic attacks are characterized by fears of a disaster or loss of self-control even though there is really nothing to worry about. Other symptoms experienced during a panic attack are heart palpitations (similar to a heart attack), shortness of breath, feelings of suffocation, and the body feels weak. If this disorder is not detected early, it will affect the daily life of the patient. This case report presents the case of a 34-year-old woman who experiences symptoms of panic disorder with choking phobia that is managed with antidepressants and cognitive behavior therapy. In addition, there is discussion of differential diagnosis and the role of cognitive behavior therapy in handling this case. 

Clinicodynamical Characteristics of Panic Disorders in Alcohol-dependent Patients

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
D. Tsygankov ◽  
D. Terekhova ◽  
E. Agasaryan
Keyword(s):  
Panic Disorder ◽  
Heavy Drinking ◽  
Alcohol Withdrawal Syndrome ◽  
Alcohol Addiction ◽  
Panic Attacks ◽  
Panic Disorders ◽  
Clinical Variants ◽  
One Year ◽  
Working Out ◽  
Abstinence From Alcohol

The aim of this study was to examine clinicodynamical characteristics of clinical course of alcohol addiction and panic disorders. Patients (n = 214) with comorbidity of alcoholism and panic disorder were included in this study.Defined and described were 4 clinical variants of associated course of these diseases that differ in formation order, cause-effect relations between alcohol abuse and panic disorder, clinical features and course of alcoholism and panic attacks, further development of double pathology.The first group included patients with full abstinence from alcohol for no less than one year by reason of panic attacks during alcohol withdrawal syndrome. The second group consisted of patients whose panic attacks were followed by ingesting considerable doses of alcohol in order to release anxiety, which resulted in the bout of heavy drinking. Episodic paroxysmal alcohol ingestion was typical in patients from the third group. Ingestion of considerable doses of alcohol leaded to panic attacks, the following abstinence from alcohol (6 months in average) was based on fear of reiteration of panic disorder. The forth group included patients with panic attacks during clinical remission of alcohol addiction who used alcohol to ease the panic symptoms. This resulted in the heavy alcoholism recurrence.The results of the study can serve as a basis for working out programs of differential therapy for above-mentioned patients.The study is supported by the President's Grant Mκ-2670.2008.7.

Changes in quality of life following cognitive-behavioral group therapy for panic disorder

2010 ◽  
Vol 25 (1) ◽  
pp. 8-14 ◽  
Author(s):  
M. Rufer ◽  
R. Albrecht ◽  
O. Schmidt ◽  
J. Zaum ◽  
U. Schnyder ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Group Therapy ◽  
Panic Disorder ◽  
Well Being ◽  
Panic Attacks ◽  
Cognitive Behavioral ◽  
Cognitive Behavioral Group Therapy ◽  
Sf 36 ◽  
Behavioral Group

AbstractBackgroundData about quality of life (QoL) are important to estimate the impact of diseases on functioning and well-being. The present study was designed to assess the association of different aspects of panic disorder (PD) with QoL and to examine the relationship between QoL and symptomatic outcome following brief cognitive-behavioral group therapy (CBGT).MethodsThe sample consisted of 55 consecutively recruited outpatients suffering from PD who underwent CBGT. QoL was assessed by the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) at baseline, post-treatment and six months follow-up. SF-36 baseline scores were compared with normative data obtained from a large German population sample.ResultsAgoraphobia, disability, and worries about health were significantly associated with decreased QoL, whereas frequency, severity and duration of panic attacks were not. Treatment responders showed significantly better QoL than non-responders. PD symptom reduction following CBGT was associated with considerable improvement in emotional and physical aspects of QoL. However, the vitality subscale of the SF-36 remained largely unchanged over time.ConclusionsOur results are encouraging for cognitive-behavior therapists who treat patients suffering from PD in groups, since decrease of PD symptoms appears to be associated with considerable improvements in QoL. Nevertheless, additional interventions designed to target specific aspects of QoL, in particular vitality, may be useful to enhance patients’ well-being.

Sleep panic attacks in patients with panic disorder: the association with major depression

1997 ◽  
Vol 12 (1) ◽  
pp. 42-43 ◽  
Author(s):  
MY Ağargün ◽  
H Kara
Keyword(s):  
Major Depression ◽  
Panic Disorder ◽  
Panic Attacks ◽  
Panic Disorders ◽  
Relationship Of ◽  
The Relationship

SummaryThe purpose of this study was to examine the relationship of sleep panic to major depression in patients with panic disorder. We found that the patients with sleep panic had a higher prevalence of major depression than subjects of other panic disorders.

Clinical staging in panic disorder and agoraphobia

2016 ◽  
Vol 33 (S1) ◽  
pp. S326-S326
Author(s):  
A. Pavlichenko
Keyword(s):  
Panic Disorder ◽  
Somatoform Disorders ◽  
Clinical Manifestations ◽  
Panic Attacks ◽  
Clinical Staging ◽  
Cognitive Symptoms ◽  
Comorbid Disorders ◽  
Prodromal Stage ◽  
Compulsive Disorder ◽  
Staging Model

There is an increasing literature about the implementation of the staging model in many mental disorders. According to this approach, there are four stages of a psychiatric disorder: prodromal stage, acute manifestations, residual phase, chronic. In this study, we empirically investigate whether additional clinical variables such as clinical manifestations and comorbid disorders may be useful to modify the staging model to panic disorder (PD).We distinguished inpatient sample (n = 79) with a diagnosis of “panic disorder” according to the DSM-IV criteria. We propose that the inclusion of prodromal stage of PD does not make clinical sense since the different unspecific neurotic symptoms may proceed to a variety of anxiety and depressive disorders. First stage was characterized by the situationally predisposed panic attacks (PA) with both somatic and cognitive symptoms. Comorbid disorders included somatoform disorders and generalized anxiety disorder (GAD). During second stage individuals experienced agoraphobic avoidance until traveling in public transport. On the other hand, spontaneous PA were accompanied by the only somatic but not cognitive symptoms. The most common patterns of comorbidity were GAD and alcohol misuse. Third stage was associated with the absence or limited symptom attacks and chronic agoraphobia. Major depression and obsessive-compulsive disorder might be an integral part of the clinical manifestations. This study supports that the staging model in PD might be updated by the detailed description of clinical manifestations and comorbid disorders at each stage that may help the practitioners to choose the best strategy for the treatment of a particular patient.Disclosure of interestThe author has not supplied his declaration of competing interest.

scholarly journals Medical rehabilitation at a new coronavirus infection (COVID-19)

2020 ◽  
Vol 2 (2) ◽  
pp. 140-189
Author(s):  
Galina E. Ivanova ◽  
Irina N. Balandina ◽  
Irina S. Bakhtina ◽  
Andrey A. Belkin ◽  
Anatoly F. Belyaev ◽  
...  
Keyword(s):  
Intensive Care ◽  
Secondary Prevention ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Medical Care ◽  
Distress Syndrome ◽  
Well Being ◽  
Medical Rehabilitation ◽  
New Variant ◽  
Coronavirus Infection

The emergence of SARS-CoV-2 and its worldwide spread has become a challenge for healthcare professionals related to rapid diagnosis of infection caused by the new coronaviruses, provision of specialized medical care, rehabilitation and secondary prevention. Currently, there is limited information on primary, secondary prevention and medical rehabilitation of this disease. The most common clinical manifestation of the new variant of coronavirus infection is bilateral pneumonia, with 34% of patients developing acute respiratory distress syndrome (ARDS). Given the unusual pandemic situation and the peculiar COVID-19 pathogenesis, the stereotyped application of generally accepted methods may be unsafe or ineffective. The Union of Rehabilitologists of Russia has prepared Temporary guidelines that are based on the advice on medical rehabilitation of patients with COVID-19 at various stages of special medical care published by WHO specialists, analysis of reports from clinics currently involved in rehabilitation of COVID-19 patients, as well as on the results of clinical studies conducted earlier on the rehabilitation of patients with Post-intensive care syndrome and adult respiratory distress syndrome (ARDS) of non-coronavirus etiology, regulatory documents of the Russian Ministry of Health and Federal Service on Surveillance for Consumer rights protection and human well-being. A syndrome-based approach to the use of means and methods of physical and rehabilitation medicine is also considered. The guidelines are intended for heads of medical organizations and their structural divisions, general practitioners, physicians, infectious disease doctors, pediatricians, emergency physicians of intensive care units in infectious hospitals, physiotherapy and sports medicine doctors, physiotherapists, medical psychologists, physical therapy instructors, nurses and other specialists of multidisciplinary rehabilitation teams working in the field of medical care for patients with COVID-19 at various stages.

Clinical aspects of depression in Parkinson's disease

2016 ◽  
Vol 33 (S1) ◽  
pp. S380-S380
Author(s):  
F. Leite ◽  
H. Salgado ◽  
O. Campos ◽  
P. Carvalho ◽  
M. Pinto da Costa ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Depressive Symptoms ◽  
Clinical Manifestations ◽  
The Elderly ◽  
Panic Attacks ◽  
Clinical Aspects ◽  
Motor Symptoms ◽  
Loss Of Self ◽  
Competing Interest

IntroductionParkinson's disease is the most common neurodegenerative movement disorder in the elderly population. The disease is clinically characterized by major motor symptoms that include bradykinesia, rigidity, tremor and postural instability. In addition to the motor symptoms, Parkinson‘s disease is characterized by emotional and cognitive deficits, which reduce quality of life independently from motor manifestations.Objectives/AimsTo discuss the clinical manifestations of depression in Parkinson's disease according to the most recent scientific literature.MethodsOnline search/review of the literature has been carried out, using Medline/Pubmed, concerning, “Parkinson's disease” and “depression”.ResultsDepression is the most frequent psychiatric disorder in Parkinson's disease. In up to 30% of the cases, the depressive symptoms precede the development of motor symptoms. Independently of the age of appearance, duration and severity of the motor symptoms, depression is generally an integral part of the disease. Depression in Parkinson's disease is generally mild or moderate, with premature loss of self-esteem and volition. Although the high rates of suicidal ideation, suicide is rare. There is also a high prevalence of panic attacks and anxiety.ConclusionsIt is difficult to correctly identify depression in Parkinson's disease as some symptoms assigned to Parkinson's disease itself can in fact be the clinical manifestation of a depressive disorder. On the other hand, depressive symptoms may not be recognized as such, but considered manifestations of Parkinson's disease.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Efficacy of Divalproex Sodium in Patients with Panic Disorder and Mood Instability Who Have Not Responded to Conventional Therapy

1998 ◽  
Vol 43 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Marilyn Baetz ◽  
Rudradeo C Bowen
Keyword(s):  
Panic Disorder ◽  
Tertiary Care ◽  
Well Being ◽  
Serum Levels ◽  
Panic Attacks ◽  
Divalproex Sodium ◽  
Behavioural Treatment ◽  
Double Blind ◽  
Mood Instability ◽  
Flexible Dose

Objective: To determine the efficacy of divalproex sodium in the treatment of psychiatric outpatients with treatment refractory panic disorder and comorbid mood instability. Method: This was an 8-week, open-trial, flexible-dose outcome study conducted at a tertiary care referral centre. Individuals with panic disorder who failed to respond to a cognitive behavioural treatment program and standard antipanic medication, who also suffered from mood instability, were chosen to participate in the study. Divalproex sodium was administered at a flexible dose to reach serum levels of 300 to 600 umol/L (45 to 90 ug/ml) unless limited by tolerance. Patients were rated by self- and rater-administered questionnaires that measured the number of panic attacks, the degree of agoraphobic avoidance, the levels of depression, anxiety, and mood swings, and the perceived sense of well being. Results: Thirteen subjects were enrolled in the study, and 10 subjects completed it. Two dropped out early because of the medication's side effects, and 1 was lost within the first month of follow-up. All 10 subjects showed significant improvement in depressive and anxiety symptoms and mood instability. There was also a statistically and clinically significant improvement in panic attacks and measures of quality of life. Conclusions: These findings suggest that divalproex sodium is useful in the treatment of patients with panic disorder and concomitant mood instability, who are refractory to conventional treatment. Double-blind trials will be required to verify these findings.

scholarly journals Justification of the possible directions of pathogenetic therapy of a new coronavirus infection

2020 ◽  
Author(s):  
YuV Lobzin ◽  
MB Ivanov ◽  
EB Shustov ◽  
VL Rejnyuk ◽  
AV Fomichev ◽  
...  
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Distress Syndrome ◽  
Clinical Manifestations ◽  
Multiple Organ ◽  
The Body ◽  
Cytotoxic Action ◽  
Sequence Of Events ◽  
Coronavirus Infection

The article analyzes the links of pathogenesis of a new coronavirus infection that lead to severe clinical manifestations of the disease – acute respiratory distress syndrome, multiple organ failure and endotoxicosis. The sequence of development of the infectious process from the moment the virus enters the body from the external environment to the damage of the alveolar-capillary barrier and the development of acute respiratory distress syndrome is presented. Factors of initiation of pathological processes leading to the development of acute respiratory distress syndrome are described, among which special attention is paid to oxidative stress, hyperreactivity of the immune system, endothelial dysfunction and cytotoxic action of the virus. Possible pharmacotherapeutic directions of COVID-19 treatment are discussed, taking into account different pathogenesis links. Flowcharts for the sequence of events during COVID-19 infection have been developed.

Sign in / Sign up

Export Citation Format

Share Document